Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · T. Rowe Price

T. Rowe Price Small-Cap Stock Fund, Inc. T. Rowe Price Small-Cap Stock Fund-I Class (OTIIX)

Ticker OTIIX · Since 2015-08-28 · · Holdings as of Jun 30, 2026

Expense ratio
0.77%$77/yr per $10k
5-yr return
+5.1%annualized
1-yr return
+8.5%as of Dec 2025
Net assets
$9.3Ball share classes
Holdings
326

Bottom line

Is OTIIX a good fund? The bottom line

OTIIX is the T. Rowe Price Small-Cap Stock Fund-I Class share class of T. Rowe Price Small-Cap Stock Fund, Inc., a managed small-cap mutual fund from T. Rowe Price.

It charges 0.77% — about $77 a year on every $10,000 invested, cheaper than 77% of small-cap funds we track.

It returned +8.5% over one year, +5.1% a year over five years, +11.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $9.3 billion in net assets and 326 holdings, its largest position is Liberty Live Holdings-c (2.5%) and the top 10 make up 16% of the portfolio.

What stands out

  • Low cost: cheaper than 77% of small-cap peers
  • Broadly diversified (326 holdings)

Updated Nov 19, 2026

What OTIIX invests in

The fund seeks to provide long-term capital growth by investing primarily in stocks of small companies.

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in stocks of small companies. Any derivatives that provide exposure to the investment focus suggested by the funds name, or to one or more market risk factors associated with the investment focus suggested by the funds name, are counted (as applicable) toward compliance with the funds 80% investment policy. The fund defines a small-cap company as a company whose market capitalization falls below the maximum market capitalization in the Russell 2000 Index, MSCI USA Small Cap Index, or MSCI World Small Cap Index (after systematically removing any companies that cannot reasonably be considered a small-cap company from the high end of the range of each index). The market capitalizations of the companies in the indexes change over time and the indexes are periodically reconstituted to…

From the fund's prospectus (filed Feb 25, 2026).

OTIIX performance

Average annual total returns
1 yr5 yr10 yr
OTIIX+8.5%+5.1%+11.0%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full OTIIX performance history →

What OTIIX costs

On a $10,000 investment, OTIIX's 0.77% expense ratio costs about $77 a year. The prospectus estimates $954 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full OTIIX fee table →

OTIIX top 10 holdings

#Holding% of fund
1Liberty Live Holdings-c2.54%
2Lattice Semiconductor Corp2.04%
3Vse Corp1.82%
4Dyne Therapeutics Inc1.67%
5Immunome Inc1.64%
6Loar Holdings Inc1.47%
7Brightspring Health Services1.34%
8Dianthus Therapeutics Inc1.21%
9Esab Corp1.14%
10Golar Lng Ltd1.13%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 16% of the fund. See all top 25 holdings and asset mix →

Alternatives to OTIIX

More funds like OTIIX →

OTIIX FAQ

What is the expense ratio of OTIIX?
OTIIX's expense ratio is 0.77%, which works out to about $77 a year for every $10,000 invested. The prospectus estimates total costs of $954 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is OTIIX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 77% of small-cap peers; broadly diversified (326 holdings). This is general information, not personalized advice.
What does OTIIX hold?
OTIIX's largest holdings are Liberty Live Holdings-c (2.5%), Lattice Semiconductor Corp (2.0%), Vse Corp (1.8%), Dyne Therapeutics Inc (1.7%), Immunome Inc (1.6%). It holds 326 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is OTIIX's 5-year return?
OTIIX returned +5.1% a year over the five years ending Dec 31, 2025, and +11.0% a year over ten years. Past performance does not guarantee future results.
Who manages OTIIX?
OTIIX is offered by T. Rowe Price through T. Rowe Price Small-Cap Stock Fund, Inc..